OncoMed Pharmaceuticals Inc (NASDAQ:OMED)

23.76
Delayed Data
As of May 04
 0.00 / 0.00%
Today’s Change
16.57
Today|||52-Week Range
29.83
+9.19%
Year-to-Date
No recent news for OncoMed Pharmaceuticals Inc.

Today’s Trading

Previous close23.76
Today’s open23.91
Day’s range-- - --
Volume123,573
Average volume (3 months)146,063
Market cap$713.1M
Dividend yield--
Data as of 05/04/2015

Growth & Valuation

Earnings growth (last year)+12.44%
Earnings growth (this year)+54.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+4.71%
P/E ratioNM
Price/Sales16.32
Price/Book9.29

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...-0.02-0.15%
TKMRTekmira Pharmaceutic...-0.06-0.41%
TGTXTG Therapeutics Inc+0.05+0.35%
ITCIIntra-Cellular Thera...+0.68+3.17%
Data as of 05/04/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$39.6M
Annual profit (last year)-$50.0M
Net profit margin-126.42%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul J. Hastings
CFO, SVP-Corporate Development &
Finance
Sunil Patel
Corporate headquarters
Redwood City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers